Armata Pharmaceuticals Inc —— 财务报表 (NYSE:ARMP) | MetaTrader

展开完整图表

新闻

H.C. Wainwright下调Armata Pharmaceuticals目标价至15美元

H.C. Wainwright lowers Armata Pharmaceuticals stock price target to $15

Armata Pharmaceuticals股价因FDA资格认定而上涨

Armata Pharmaceuticals stock gains on FDA designation

FDA授予Armata葡萄球菌感染疗法QIDP资格

FDA grants QIDP status to Armata’s staph infection treatment

Innoviva stock gains BTIG coverage with buy rating on royalty windfall

Armata to advance bacteriophage therapy to phase 3 for S. aureus

Jones Trading 给予 Armata Pharmaceuticals 股票买入评级

Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating

Armata PharmaQ3每股收益及营收逊于预期

Armata Pharma earnings missed by $0.24, revenue fell short of estimates